The total number of oncology treatment cases, which includes the utilization of drugs, particularly targeted ones that effectively inhibit tumor growth and spreading, funded by compulsory health insurance, has demonstrated an impressive surge of 63.6% since the year 2019. The Minister of Health of the Russian Federation, Mikhail Murashko, made this announcement. Furthermore, as stated by the minister, there has been a significant increase in the number of detected cancer cases at early stages, accounting for an impressive 60% already.
“The number of cases of treatment using antitumor drug therapy, including targeted drugs, at the expense of compulsory medical insurance funds has increased by 63.6%. Thanks to our joint dedicated work, during this time we have been able to make a qualitative leap in the provision of medical care to patients with cancer,” the minister said in his greeting at the VI International Forum of Oncology and Radiotherapy “For Life.”
During this period, it was observed that there was a significant reduction in the one-year mortality rate of patients with malignant neoplasms by 14%, as well as a decrease of 5.6% in the overall mortality rate of the population due to malignant neoplasms, compared to the statistics recorded in 2018.
